NO20006381D0 - Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents - Google Patents

Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents

Info

Publication number: NO20006381D0
Authority: NO; Norway
Prior art keywords: serm; selective; growth hormone; estrogen receptor; receptor modulators
Prior art date: 1998-06-16

Application number

NO20006381A

Other languages

Norwegian (no)

Other versions

NO20006381L (en

Inventor

Hua Zhu Ke

Mei Li

Lydia Codetta Pan

David Duane Thompson

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-12-14

Publication date

2000-12-14

2000-12-14 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-12-14 Publication of NO20006381D0 publication Critical patent/NO20006381D0/en

2000-12-14 Publication of NO20006381L publication Critical patent/NO20006381L/en

Links

102000018997 Growth Hormone Human genes 0.000 title 1
108010051696 Growth Hormone Proteins 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
239000002834 estrogen receptor modulator Substances 0.000 title 1
239000000122 growth hormone Substances 0.000 title 1
230000028327 secretion Effects 0.000 title 1
239000000333 selective estrogen receptor modulator Substances 0.000 title 1
229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20006381A 1998-06-16 2000-12-14 Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents NO20006381L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8942498P	1998-06-16	1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en)	1998-06-16	1999-05-03	Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number	Publication Date
NO20006381D0 true NO20006381D0 (en)	2000-12-14
NO20006381L NO20006381L (en)	2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006381A NO20006381L (en)	1998-06-16	2000-12-14	Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents

Country Status (29)

Country	Link
EP (1)	EP1085867A1 (en)
JP (1)	JP2002518328A (en)
KR (1)	KR20010052817A (en)
CN (1)	CN1305378A (en)
AP (1)	AP9901581A0 (en)
AR (1)	AR018868A1 (en)
AU (1)	AU3342099A (en)
BG (1)	BG105128A (en)
BR (1)	BR9911357A (en)
CA (1)	CA2335112A1 (en)
CO (1)	CO5070586A1 (en)
EA (1)	EA200001189A1 (en)
GT (1)	GT199900083A (en)
HR (1)	HRP20000857A2 (en)
HU (1)	HUP0102395A2 (en)
ID (1)	ID26726A (en)
IL (1)	IL139587A0 (en)
IS (1)	IS5727A (en)
MA (1)	MA26648A1 (en)
NO (1)	NO20006381L (en)
OA (1)	OA11569A (en)
PA (1)	PA8472101A1 (en)
PE (1)	PE20000633A1 (en)
PL (1)	PL345064A1 (en)
SK (1)	SK18902000A3 (en)
TN (1)	TNSN99118A1 (en)
UY (1)	UY25557A1 (en)
WO (1)	WO1999065488A1 (en)
ZA (1)	ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1004306A3 (en) *	1998-08-06	2000-06-07	Pfizer Products Inc.	Estrogen agonists/antagonists
CA2420535A1 (en) *	2000-08-30	2002-03-07	Mary Tanya Am Ende	Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
MXPA04005112A (en) *	2001-11-29	2005-04-29	Gtx Inc	Prevention and treatment of androgen-deprivation induced osteoporosis.
US7524866B2 (en)	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
ES2602789T3 (en)	2007-02-09	2017-02-22	Ocera Therapeutics, Inc.	Connector intermediates for the synthesis of macrocyclic modulators of the ghrelin receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (en) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS

1999
- 1999-05-03 AU AU33420/99A patent/AU3342099A/en not_active Abandoned
- 1999-05-03 WO PCT/IB1999/000796 patent/WO1999065488A1/en not_active Ceased
- 1999-05-03 IL IL13958799A patent/IL139587A0/en unknown
- 1999-05-03 EA EA200001189A patent/EA200001189A1/en unknown
- 1999-05-03 OA OA1200000346A patent/OA11569A/en unknown
- 1999-05-03 CN CN99807381A patent/CN1305378A/en active Pending
- 1999-05-03 KR KR1020007014140A patent/KR20010052817A/en not_active Ceased
- 1999-05-03 EP EP99914723A patent/EP1085867A1/en not_active Withdrawn
- 1999-05-03 JP JP2000554368A patent/JP2002518328A/en active Pending
- 1999-05-03 PL PL99345064A patent/PL345064A1/en unknown
- 1999-05-03 HU HU0102395A patent/HUP0102395A2/en unknown
- 1999-05-03 HR HR20000857A patent/HRP20000857A2/en not_active Application Discontinuation
- 1999-05-03 CA CA002335112A patent/CA2335112A1/en not_active Abandoned
- 1999-05-03 SK SK1890-2000A patent/SK18902000A3/en unknown
- 1999-05-03 BR BR9911357-0A patent/BR9911357A/en not_active Application Discontinuation
- 1999-05-03 ID IDW20002604A patent/ID26726A/en unknown
- 1999-05-07 PA PA19998472101A patent/PA8472101A1/en unknown
- 1999-06-10 AP APAP/P/1999/001581A patent/AP9901581A0/en unknown
- 1999-06-11 UY UY25557A patent/UY25557A1/en not_active Application Discontinuation
- 1999-06-11 PE PE1999000522A patent/PE20000633A1/en not_active Application Discontinuation
- 1999-06-14 GT GT199900083A patent/GT199900083A/en unknown
- 1999-06-15 ZA ZA9903973A patent/ZA993973B/en unknown
- 1999-06-15 AR ARP990102847A patent/AR018868A1/en not_active Application Discontinuation
- 1999-06-15 MA MA25622A patent/MA26648A1/en unknown
- 1999-06-15 TN TNTNSN99118A patent/TNSN99118A1/en unknown
- 1999-06-16 CO CO99037624A patent/CO5070586A1/en unknown
2000
- 2000-11-24 IS IS5727A patent/IS5727A/en unknown
- 2000-12-14 NO NO20006381A patent/NO20006381L/en not_active Application Discontinuation
2001
- 2001-01-08 BG BG105128A patent/BG105128A/en unknown

Also Published As

Publication number	Publication date
SK18902000A3 (en)	2001-12-03
JP2002518328A (en)	2002-06-25
BG105128A (en)	2001-11-30
PL345064A1 (en)	2001-11-19
IS5727A (en)	2000-11-24
AU3342099A (en)	2000-01-05
BR9911357A (en)	2001-03-13
HRP20000857A2 (en)	2001-10-31
ZA993973B (en)	2000-12-15
WO1999065488A1 (en)	1999-12-23
CO5070586A1 (en)	2001-08-28
OA11569A (en)	2004-07-01
CA2335112A1 (en)	1999-12-23
UY25557A1 (en)	2001-01-31
PA8472101A1 (en)	2000-09-29
HUP0102395A2 (en)	2001-11-28
KR20010052817A (en)	2001-06-25
AR018868A1 (en)	2001-12-12
CN1305378A (en)	2001-07-25
PE20000633A1 (en)	2000-07-26
ID26726A (en)	2001-02-01
GT199900083A (en)	2000-12-05
AP9901581A0 (en)	1999-06-30
TNSN99118A1 (en)	2005-11-10
EP1085867A1 (en)	2001-03-28
NO20006381L (en)	2000-12-14
EA200001189A1 (en)	2001-06-25
IL139587A0 (en)	2002-02-10
MA26648A1 (en)	2004-12-20

Similar Documents

Publication	Publication Date	Title
NO20025143D0 (en)	2002-10-25	Modulators of receptors for parathyroid hormone and parathyroid hormone-linked protein
NO20020912D0 (en)	2002-02-25	Bicyclic androgen and progesterone receptor modulator compounds and methods
NO20024478D0 (en)	2002-09-19	Hormone replacement therapy using combination of conjugated estrogens and medroxyprogesterone acetate
NO981426D0 (en)	1998-03-30	Method and apparatus for primary-well cementing
IL139915A0 (en)	2002-02-10	Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
IS1886B (en)	2003-09-01	Controlled release of steroid sugar
EE200100053A (en)	2002-06-17	Use of biogenic estrogen sulfamates for hormone replacement therapy
AU4134101A (en)	2001-05-30	Hormone receptor functional entities and methods of their use
DE69838202D1 (en)	2007-09-20	End point sensation and apparatus
DK1089719T3 (en)	2002-08-05	Transdermal therapeutic system containing hormones and crystallization inhibitors
NO991593D0 (en)	1999-03-31	Hormone preparation consisting of a ° estrogen compound and a progesterone compound
DK0994706T3 (en)	2006-03-06	Preparations for oral administration of taxanes and their use
NO20006313L (en)	2000-12-12	Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
NO20006312D0 (en)	2000-12-12	Therapeutic mixtures of selective estrogen receptor modulators (SERM) and growth hormone secretion stimulant (GHS) for the treatment of musculoskeletal fragility
EE05172B1 (en)	2009-06-15	Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological diseases
NO20021947L (en)	2002-06-14	Bio-borne matrices, method of preparation and use thereof
CY2228B1 (en)	2003-04-18	Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
IS5727A (en)	2000-11-24	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
NO20032969D0 (en)	2003-06-27	Method of Screening for Progesterone Receptor Isoform-Specific Ligands and for Tissue Selective Progesterone Receptor Ligands
LT97021A (en)	1998-02-25	Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PL342666A1 (en)	2001-07-02	Method of testing therapeutic agents
AU1270099A (en)	1999-05-03	Human progesterone receptor complex p23-like protein
DK1047668T3 (en)	2003-08-11	Triazepinones, method of preparation thereof and therapeutic use thereof
SI1265616T1 (en)	2006-08-31	Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
AU4562100A (en)	2000-12-05	Method for passing a mixture of liquid through human and/or animal organs or extremities

Legal Events

Date	Code	Title	Description
2003-01-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application